Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc. (0HIY)

Market Closed
1 Sep, 15:30
LSE LSE
$
9. 13
+0.23
+2.5685%
$
- Market Cap
- P/E Ratio
- Div Yield
217 Volume
-2.6 Eps
$ 8.9
Previous Close
Add Transaction
Day Range
8.8 9.24
Year Range
4.02 19.05
Want to track 0HIY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Atara Biotherapeutics, Inc. (0HIY) Statistics

Valuation metrics

Market Cap -
Enterprise value 89.55M
Trailing P/E (ttm) -7.8
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 13.38
Price/Book (mrq) -3.74
Enterprise Value/Revenue 14.46
Enterprise Value/EBITDA -6.56

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 691
Average volume (90 days) 1.49K

Price summary

52-Week low 4.02
52-Week high 19.05
Beta -
50-Day moving average 8.66
200-Day moving average 7.54

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.04:1
Last split Date 20 Jun 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -2.69%
Operating margin -2.3%

Operational effectiveness

Return on assets -0.79%
Return on equity 0.45%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.41
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.11
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.66
Total debt (mrq) -
Total Debt/Equity (mrq) -0.27
Current ratio (mrq) 1.98%
Book value per share (mrq) -2.46

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -